Helen Parker
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research 15
- Genomic variations and chromosomal abnormalities 8
- Hematology top 5%
-
- Lymphoma Diagnosis and Treatment 13
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 6
-
- Acute Lymphoblastic Leukemia research 5
- Research on Leishmaniasis Studies 4
-
- Lysosomal Storage Disorders Research 11
-
- Immunodeficiency and Autoimmune Disorders 7
- Co-authors
- Jonathan C. StreffordBrian BiggerDavid OscierMatthew Rose‐ZerilliAndrew CollinsChristine J. HarrisonAnthony V. MoormanStuart Ellison
- Partner nations
- United KingdomUnited StatesSpain
In The Last Decade
Helen Parker
46 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 73
- Genetics 404
- Hematology 296
- Pathology and Forensic Medicine 325
- Cancer Research 165
- Public Health, Environmental and Occupational Health 292
Countries citing papers authored by Helen Parker
This map shows the geographic impact of Helen Parker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Parker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Parker more than expected).
Fields of papers citing papers by Helen Parker
This network shows the impact of papers produced by Helen Parker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Parker. The network helps show where Helen Parker may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Helen Parker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 5 | |
| 3 | 2023 | 28 | |
| 4 | 2022 | 8 | |
| 5 | 2021 | 11 | |
| 6 | 2020 | 39 | |
| 7 | An improved AAV vector for neurological correction of the mouse model of Mucopolysaccharidosis IIIA | 2019 | 1 |
| 8 | 2019 | 16 | |
| 9 | 2019 | 14 | |
| 10 | 2019 | 23 | |
| 11 | 2018 | 1 | |
| 12 | 2015 | 67 | |
| 13 | 2014 | 46 | |
| 14 | 2013 | 51 | |
| 15 | 2011 | 9 | |
| 16 | 2010 | 75 | |
| 17 | 2009 | 33 | |
| 18 | 2008 | 134 | |
| 19 | 2008 | 43 | |
| 20 | 2008 | 23 |
About Helen Parker
Helen Parker is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology, having authored 48 papers that have together received 1.3k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (15 papers), Lymphoma Diagnosis and Treatment (13 papers), Lysosomal Storage Disorders Research (11 papers), Genomic variations and chromosomal abnormalities (8 papers), Immunodeficiency and Autoimmune Disorders (7 papers), Cancer Genomics and Diagnostics (6 papers), Acute Lymphoblastic Leukemia research (5 papers) and Research on Leishmaniasis Studies (4 papers). The work is most often cited by research in Genetics (404 citations), Hematology (296 citations) and Pathology and Forensic Medicine (325 citations). Helen Parker has collaborated with scholars based in United Kingdom, United States and Spain. Frequent co-authors include Jonathan C. Strefford, Brian Bigger, David Oscier, Matthew Rose‐Zerilli, Andrew Collins, Christine J. Harrison, Anthony V. Moorman, Stuart Ellison, Jade Forster and Lynne Minto. Their work appears in journals such as Blood, Molecular Genetics and Metabolism, Leukemia, Haematologica and Molecular Therapy — Methods & Clinical Development.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.